Literature DB >> 33113001

Trends in psoriatic arthritis epidemiology in Poland.

Małgorzata Tłustochowicz1, Waldemar Wierzba2, Michał Marczak3, Witold Tłustochowicz4, Andrzej Śliwczyński2, Filip Raciborski5, Brygida Kwiatkowska6, Melania Brzozowska3,7, Andrzej Jacyna8, Bartłomiej Kisiel4.   

Abstract

Psoriatic arthritis (PsA) is a heterogeneous inflammatory arthritis, usually seronegative and associated with psoriasis (Ps). The prevalence and incidence of psoriatic arthritis show strong ethnic and geographic variations. The aim of the study was to assess the epidemiological trends in psoriatic arthritis in Poland. The National Health Fund (NHF) database for the period 2008-2018 was analyzed. PsA was defined as ICD-10 codes L40.5, M07, M07.0, M07.1, M07.2 and M07.3, while psoriasis as ICD-10 codes L40 and L40.X (L40.0 to L40.9). A steady increase in the number of PsA patients (from 16,790 to 32,644) and in PsA recorded prevalence (from 38.47 per 100,000 in 2008 to 73.11 per 100,000 in 2018) was observed between 2008 and 2018. The PsA/Ps ratio increased to a similar extent (from 8.3 to 17.5%). The percentage of PsA patients receiving rehabilitation services remained constant throughout the observation period (mean: 17.35%; range 16.7-18.9%). The study showed a steady and continuous increase in PsA recorded prevalence. A simultaneous increase in the PsA/Ps ratio suggests that the main reason for the observed trend is greater disease detection .

Entities:  

Keywords:  Epidemiology; Prevalence; Psoriasis; Psoriatic arthritis

Year:  2020        PMID: 33113001      PMCID: PMC7806568          DOI: 10.1007/s00296-020-04734-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  22 in total

Review 1.  The Epidemiology of Psoriatic Arthritis.

Authors:  Alexis Ogdie; Pamela Weiss
Journal:  Rheum Dis Clin North Am       Date:  2015-09-11       Impact factor: 2.670

2.  Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics.

Authors:  Philip J Mease; Dafna D Gladman; Kim A Papp; Majed M Khraishi; Diamant Thaçi; Frank Behrens; Robert Northington; Joanne Fuiman; Eustratios Bananis; Robert Boggs; Daniel Alvarez
Journal:  J Am Acad Dermatol       Date:  2013-08-24       Impact factor: 11.527

Review 3.  Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis.

Authors:  Axel Patrice Villani; Marie Rouzaud; Morgane Sevrain; Thomas Barnetche; Carle Paul; Marie-Aleth Richard; Marie Beylot-Barry; Laurent Misery; Pascal Joly; Michel Le Maitre; Selim Aractingi; François Aubin; Alain Cantagrel; Jean-Paul Ortonne; Denis Jullien
Journal:  J Am Acad Dermatol       Date:  2015-06-06       Impact factor: 11.527

4.  Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies.

Authors:  Farzad Alinaghi; Monika Calov; Lars Erik Kristensen; Dafna D Gladman; Laura C Coates; Denis Jullien; Alice B Gottlieb; Paolo Gisondi; Jashin J Wu; Jacob P Thyssen; Alexander Egeberg
Journal:  J Am Acad Dermatol       Date:  2018-06-19       Impact factor: 11.527

5.  Risk of myocardial infarction in patients with psoriasis.

Authors:  Joel M Gelfand; Andrea L Neimann; Daniel B Shin; Xingmei Wang; David J Margolis; Andrea B Troxel
Journal:  JAMA       Date:  2006-10-11       Impact factor: 56.272

Review 6.  Update on the epidemiology, risk factors, and disease outcomes of psoriatic arthritis.

Authors:  Dilek Solmaz; Lihi Eder; Sibel Zehra Aydin
Journal:  Best Pract Res Clin Rheumatol       Date:  2018-10-05       Impact factor: 4.098

Review 7.  Prevalence and incidence of psoriatic arthritis: A systematic review and meta-analysis.

Authors:  Lorenza Scotti; Matteo Franchi; Antonio Marchesoni; Giovanni Corrao
Journal:  Semin Arthritis Rheum       Date:  2018-01-06       Impact factor: 5.532

8.  Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden--a population-based register study.

Authors:  Sofia Löfvendahl; Elke Theander; Åke Svensson; Katarina Steen Carlsson; Martin Englund; Ingemar F Petersson
Journal:  PLoS One       Date:  2014-05-29       Impact factor: 3.240

9.  Prevalence of psoriatic arthritis and costs generated by treatment of psoriatic arthritis patients in the public health system - the case of Poland.

Authors:  Filip Raciborski; Andrzej Śliwczyński; Anna Kłak; Brygida Kwiatkowska; Melania Brzozowska; Małgorzata Tłustochowicz
Journal:  Reumatologia       Date:  2016-12-30

10.  The epidemiology of psoriatic arthritis in Israel - a population-based study.

Authors:  Lihi Eder; Arnon Dov Cohen; Ilan Feldhamer; Sari Greenberg-Dotan; Erez Batat; Devy Zisman
Journal:  Arthritis Res Ther       Date:  2018-01-02       Impact factor: 5.156

View more
  1 in total

1.  Chronic Plaque Psoriasis in Poland: Disease Severity, Prevalence of Comorbidities, and Quality of Life.

Authors:  Dorota Purzycka-Bohdan; Anna Kisielnicka; Monika Zabłotna; Bogusław Nedoszytko; Roman J Nowicki; Adam Reich; Dominik Samotij; Justyna Szczęch; Dorota Krasowska; Joanna Bartosińska; Joanna Narbutt; Aleksandra Lesiak; Paulina Barasińska; Agnieszka Owczarczyk-Saczonek; Joanna Czerwińska; Jacek C Szepietowski; Aleksandra Batycka-Baran; Rafał Czajkowski; Magdalena Górecka-Sokołowska; Lidia Rudnicka; Joanna Czuwara; Marta Sobalska-Kwapis; Dominik Strapagiel; Aneta Szczerkowska-Dobosz
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.